Annulling a dangerous liaison: vaccination strategies against AIDS and tuberculosis
SHE Kaufmann, AJ McMichael - Nature medicine, 2005 - nature.com
Human immunodeficiency virus (HIV) and Mycobacterium tuberculosis annually cause 3
million and 2 million deaths, respectively. Last year, 600,000 individuals, doubly infected …
million and 2 million deaths, respectively. Last year, 600,000 individuals, doubly infected …
Correlation between immunologic responses to a recombinant glycoprotein 120 vaccine and incidence of HIV-1 infection in a phase 3 HIV-1 preventive vaccine trial
PB Gilbert, ML Peterson, D Follmann… - The Journal of …, 2005 - academic.oup.com
Background An objective of the first efficacy trial of a candidate vaccine containing
recombinant human immunodeficiency virus (HIV) type 1 envelope glycoprotein 120 …
recombinant human immunodeficiency virus (HIV) type 1 envelope glycoprotein 120 …
[PDF][PDF] Immunopathogenesis of HIV infection
RS Paranjape - Indian J Med Res, 2005 - researchgate.net
Progression of HIV infection is largely dependent on the interaction between the viral factors
and host factors. HIV primarily infects the CD4 lymphocytes in the body. It brings about the …
and host factors. HIV primarily infects the CD4 lymphocytes in the body. It brings about the …
Therapeutic Vaccination of HIV-1-Infected Patients on Haart with a Recombinant HIV-1 Nef-Expressing Mva: Safety, Immunogenicity and Influence on Viral Load …
E Harrer, M Bäuerle, B Ferstl, P Chaplin… - Antiviral …, 2005 - journals.sagepub.com
The safety and immunogenicity of an HIV-1 nef-expressing modified vaccinia virus Ankara
(MVA) was investigated in 14 HIV-1-positive patients (CD4> 400/μl) on highly active …
(MVA) was investigated in 14 HIV-1-positive patients (CD4> 400/μl) on highly active …
Combined effect of CCR5-Δ32 heterozygosity and the CCR5 promoter polymorphism− 2459 A/G on CCR5 expression and resistance to human immunodeficiency …
F Hladik, H Liu, E Speelmon… - Journal of …, 2005 - Am Soc Microbiol
Exposed seronegative individuals (ES) with persistent high-risk sexual behavior may be less
susceptible to human immunodeficiency virus type 1 (HIV-1) infection because they carry the …
susceptible to human immunodeficiency virus type 1 (HIV-1) infection because they carry the …
Human immunodeficiency virus mutations during the first month of infection are preferentially found in known cytotoxic T-lymphocyte epitopes
F Bernardin, D Kong, L Peddada… - Journal of …, 2005 - Am Soc Microbiol
The full protein coding region of human immunodeficiency virus (HIV) genomes were
sequenced using plasma collected from nine African-Americans prior to seroconversion and …
sequenced using plasma collected from nine African-Americans prior to seroconversion and …
MHC, health, color, and reproductive success in sand lizards
Abstract “Good genes” are genetic elements that contribute to lifetime reproductive success,
regardless of an individual's additional genotype. Their existence is debated, and most work …
regardless of an individual's additional genotype. Their existence is debated, and most work …
CD8+ T-Cell-Mediated Cross-Clade Protection in the Genital Tract following Intranasal Immunization with Inactivated Human Immunodeficiency Virus Antigen Plus …
JQ Jiang, A Patrick, RB Moss, KL Rosenthal - Journal of virology, 2005 - Am Soc Microbiol
Human immunodeficiency virus (HIV) is a mucosally transmitted infection that rapidly targets
and depletes CD4+ T cells in mucosal tissues and establishes a major reservoir for viral …
and depletes CD4+ T cells in mucosal tissues and establishes a major reservoir for viral …
Major histocompatibility complex class II (HLA-DRB and-DQB) allele frequencies in Botswana: association with human immunodeficiency virus type 1 infection
T Ndung'u, S Gaseitsiwe, E Sepako… - Clinical and Vaccine …, 2005 - Am Soc Microbiol
Southern Africa is facing an unprecedented public health crisis due to the high prevalence of
human immunodeficiency virus type 1 (HIV-1). Vaccine development and testing efforts …
human immunodeficiency virus type 1 (HIV-1). Vaccine development and testing efforts …
The CD160+ CD8high cytotoxic T cell subset correlates with response to HAART in HIV-1+ patients
MH Nikolova, MN Muhtarova, HB Taskov, K Kostov… - Cellular …, 2005 - Elsevier
We investigated the circulating cytotoxic CD160+ CD8high subset in correlation to antiviral
immunity and response to highly active antiretroviral therapy (HAART) in HIV+ subjects. The …
immunity and response to highly active antiretroviral therapy (HAART) in HIV+ subjects. The …